How do regulatory standards address the need for effective communication mechanisms for patients with special transfusion needs such as irradiated blood?
In general, regulatory standards require that there be an established
- policy defining when irradiated cellular blood products are required to prevent transfusion-associated graft-versus-host disease
- process to ensure that recipients of irradiated products continue to receive them as long as clinically indicated
Such policies and processes are required for all special transfusion needs, not just irradiated blood. They also require effective communication between everyone involved in blood transfusion.